Humana has its last trading day on Nasdaq Stockholm today before delisting

Humana and UnitedHealthcare are canceling Medicare Advantage plans affecting 1 million seniors. Humana's move impacts 600,000 enrollees, while UnitedHealthcare's decision affects 390,000 members, citing rising costs and demand. Both companies offer alternative plans.

Humana and UnitedHealthcare are discontinuing some Medicare Advantage plans, affecting about 1 million seniors. Humana's decision impacts 600,000 enrollees, while UnitedHealthcare's affects 390,000. Both companies cited higher costs and increased plan usage as reasons, and will offer alternative plans to most affected members.

Humana reported Q3 revenue of SEK 2,592m, up 4% YoY, with adjusted operating profit increasing 6% to SEK 221m. EBITDA rose to SEK 360m, and net profit reached SEK 123m. Growth was driven by price increases and efficiency improvements in Sweden, while Norway showed strong organic growth. Humana was acquired by Ambea and will delist from Nasdaq Stockholm. The company did not provide a new earnings forecast.

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans covering nearly 1 million members, withdrawing from less profitable markets. UnitedHealthcare is ending plans for 390,000 members, while Humana is cutting 600,000. Both companies are focusing on more profitable products and regions, according to reports. Rising medical costs are driving these changes, with insurers reducing flexible PPO plans and increasing out-of-pocket expenses for members.

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans affecting nearly 1 million Americans in 2027, citing higher medical expenses and profitability pressures. UnitedHealthcare will impact 390,000 members, focusing on PPO plans, while Humana will affect 600,000 members, targeting lower-performing plans. Both companies are also scaling back certain benefits for 2027, with UnitedHealthcare reducing dental benefits and Humana adjusting premium givebacks.

Humana (HUM) agreed to a $2.8 bn deal with BlackRock, restructuring ownership of 150 CenterWell clinics. BlackRock acquires WCAS's majority stake, with Humana retaining minority ownership. The deal reduces Humana's balance sheet obligations. Humana's Medicare Advantage star ratings improved, potentially increasing 2028 bonus payments to $4.8 bn, per Evercore ISI. S&P affirmed Humana's BBB rating but maintained a negative outlook.